U09.9
Conditions
Interventions
Group 1: Post-COVID Experimental Group: Group Psychotherapy with a focus on psychoeducation (8 sessions of 90 minutes each within 8 weeks, plus 1 pre- and 1 post-test session of 90 minutes each, total
Sponsors
Universitätsklinikum Frankfurt, Klinik für Psychiatrie, Psychosomatik und Psychotherapie
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: •Diagnosis of neuropsychiatric symptoms in the context of post-COVID-syndrome according to WHO criteria (ICD-10 U09.9; WHO, 2019). •Age between 18 and 65 •Patients who are able to work/not on sick leave and patients who are unable to work/on sick leave during the intervention phase •Sufficient knowledge of German •Outpatients •Stable antidepressant medication in the last 4 weeks before the start of the intervention
Exclusion criteria
Exclusion criteria: •Acute suicidality •Current severe depressive episode •Current psychotic symptoms or history of psychotic symptoms •Bipolar disorder •Current substance use, substance dependence, or substance abuse •Antisocial, schizotypal, or borderline personality disorder •Other primary diagnosis according to ICD-10 (WHO, 2021) •Other ongoing psychotherapy •Serious somatic problems that prevent attendance at group therapy sessions or serious internal medical conditions •Any other severe neurological disease, current or in the past (e.g., condition after cerebral hemorrhage, cerebral ischemia, dementia, multiple sclerosis, severe traumatic brain injury) •Pregnancy or breastfeeding •Individuals who are dependent on or employed by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of chronic exhaustion and work-related stress tolerance, measured with the Chandler Fatigue Scale (Martin et al., 2010), the Fatigue Impact Scale (FIS; Fisk et al., 1994) , and the psychosocial dimension of the Fatigue Severity Scale (FSS; Krupp et al., 1989), the Quality of Life Scale (German version of the WHOQOL-BREF; WHO, 2012), the German version of the Occupational Depression Inventory (ODI; Bianchi & Schonfeld, 2020), the Work Ability Index (WAI; Freyer, Formazin & Rose, 2019), the Return to Work Attitude Self-efficacy Questionnaire (RTW-SE), and the Effort-Reward-Imbalance Questionnaire (ERI; Siegrist et al., 2016); assessed before and after group psychotherapy (pre-/post-test session) | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom reduction, measured using the German version of the Montgomery-Asberg Depression Scale (MADRS; Montgomery & Asberg, 1979), the German version of the Quick Inventory of Depressive Symptomatology (QIDS SR-16; Rush et al., 2003), and the Scale for Dysfunctional Depressive Cognitions (DAS; Hautzinger et al., 1983) and the Patient Health Questionnaire-D (PHQ-D; Löwe, 2015); assessed before and after group psychotherapy (pre-/post-test session) Number of sick days at work; assessed before group psychotherapy (pre-test session) and after 10 weeks (post-test session) | — |
Countries
Germany
Contacts
Public ContactViola Oertel
Universitätsklinikum Frankfurt, Klinik für Psychiatrie, Psychosomatik und Psychotherapie
Outcome results
None listed